Lucigen Corp., a Middleton biotech firm, said Monday it has been awarded $350,000 in grants from the National Institutes of Health to fund additional research and development. The two grants will be used to develop genetic sequencing tools, and to create an affordable tool to help researchers study data from genes and proteins within individual cells. Read full Journal Sentinel story here.
Diverse businesses get a leg up as #funding + support expands across northern #Wisconsin. http://ow.ly/vx2l50LLCY3 via @WPR #diversitymatters
Congrats to the 2022 Red Letter Grant recipients! These grants aim to encourage more #women to take risks, build a more innovative region + state, and lead. http://ow.ly/PUtK50LLCUZ #startup #entrepreneur
Many thanks to our panelists + all who joined us yesterday to learn more about metabolic #health #research @Morgridge_Inst + @UWMadison! http://ow.ly/jAXi50LLCPn #innovation2
Morgridge CEO Brad Schwartz introduces the importance of #metabolism research at the @WiscTechCouncil Innovation Network luncheon. #FearlessScience